+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

E

Actively Recruiting

Healthy Volunteer

Researchers are evaluating the safety, tolerability, and immune response of the rVSV94G-LASV-GPC vaccine in adults and children living in West Africa. This Phase 2 clinical trial builds on earlier studies that showed the vaccine to be safe and able to protect animals against Lassa Fever. The study includes healthy adults, HIV-infected adults, adolescents, and children to better understand the vaccines effects across these groups and prepare for future effectiveness trials. Participants will receive one of three different doses of the rVSV94G-LASV-GPC vaccine or a placebo in a randomized, double-blinded manner. The vaccine is given as a single dose on Day 1. The study includes separate cohorts for healthy adults aged 18-70, HIV-infected adults aged 18-50, adolescents aged 12-17, and children aged 6-11. The study will observe vaccine safety and immune responses over various time points up to 7 months and beyond in some cases. During the study, participants will undergo medical exams, HIV testing, and monitoring for vaccine-related side effects. Researchers will measure antibody responses, vaccine presence in blood and body fluids, and immune system characteristics. Participants will be followed for safety and the duration of immune responses for up to 30 months in some cases. The study aims to provide detailed information on how well the vaccine is tolerated and how it stimulates the immune system in different age and health groups.

Age: 6Years - 70YearsAll GendersPhase 2
3 locations
E

Actively Recruiting

This research aims to understand how national medical oxygen strategies work and achieve impact at both national and local levels across different countries. It focuses on health systems and policy contexts in six countries involved in the Medical Oxygen Implementation program. The study seeks to involve policymakers, implementers, and medical oxygen users to identify challenges and find potential solutions to improve access to medical oxygen. Researchers also aim to generate new data and draw lessons that can inform national and global policy and practice. The study uses a mixed-methods design with three embedded parts stakeholder analysis, policy-implementation gap analysis, and comparative country case studies. It involves interviews with key informants from government, NGOs, professional associations, private sector, and civil society. The study is conducted in six countries and will be adapted to each context through ongoing collaboration with stakeholders. The research will run for four years and includes annual meetings to refine study topics and methods. Participants will take part in in-depth interviews focusing on national medical oxygen strategies over the four-year study period. Researchers will review policies, analyze program data, and compare findings across countries. The study will monitor how strategies are translated into action and their effects on oxygen service coverage. This involves collecting qualitative and quantitative data to better understand the implementation and challenges of medical oxygen programs within different health systems.

Age: 18Years +All Genders
6 locations